TRAD CHI MED (00570) Sets 20 March 2026 Board Meeting to Approve FY 2025 Results and Evaluate Final Dividend

Bulletin Express

03/10

China Traditional Chinese Medicine Holdings Co. Limited (TRAD CHI MED, 00570) will convene a board meeting on 20 March 2026 to review and approve the consolidated financial results for the year ended 31 December 2025. The agenda also includes deliberation on the declaration of a potential final dividend.

The board currently comprises 12 directors: three executive directors (YANG Jun, LI Hongjian, PENG Li), five non-executive directors (LIU Haijian, LI Xiangrong, ZU Jing, XU Jinghui, HUANG Hao) and four independent non-executive directors (XIE Rong, YU Tze Shan Hailson, QIN Ling, LI Weidong).

The company disclosed the meeting schedule through an announcement filed with the Hong Kong Stock Exchange on 10 March 2026.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/news/1176253694"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1176253694\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1176253694?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-10 16:43","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1176253694","market":"us","top_or_hot":-1,"title":"TRAD CHI MED (00570) Sets 20 March 2026 Board Meeting to Approve FY 2025 Results and Evaluate Final Dividend","media":"Bulletin Express","content":"<p>China Traditional Chinese Medicine Holdings Co. Limited (TRAD CHI MED, 00570) will convene a board meeting on 20 March 2026 to review and approve the consolidated financial results for the year ended 31 December 2025. The agenda also includes deliberation on the declaration of a potential final dividend.</p>\n<p>The board currently comprises 12 directors: three executive directors (YANG Jun, LI Hongjian, PENG Li), five non-executive directors (LIU Haijian, LI Xiangrong, ZU Jing, XU Jinghui, HUANG Hao) and four independent non-executive directors (XIE Rong, YU Tze Shan Hailson, QIN Ling, LI Weidong).</p>\n<p>The company disclosed the meeting schedule through an announcement filed with the Hong Kong Stock Exchange on 10 March 2026.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>TRAD CHI MED (00570) Sets 20 March 2026 Board Meeting to Approve FY 2025 Results and Evaluate Final Dividend</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTRAD CHI MED (00570) Sets 20 March 2026 Board Meeting to Approve FY 2025 Results and Evaluate Final Dividend\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time smaller\">2026-03-10 16:43</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>China Traditional Chinese Medicine Holdings Co. Limited (TRAD CHI MED, 00570) will convene a board meeting on 20 March 2026 to review and approve the consolidated financial results for the year ended 31 December 2025. The agenda also includes deliberation on the declaration of a potential final dividend.</p>\n<p>The board currently comprises 12 directors: three executive directors (YANG Jun, LI Hongjian, PENG Li), five non-executive directors (LIU Haijian, LI Xiangrong, ZU Jing, XU Jinghui, HUANG Hao) and four independent non-executive directors (XIE Rong, YU Tze Shan Hailson, QIN Ling, LI Weidong).</p>\n<p>The company disclosed the meeting schedule through an announcement filed with the Hong Kong Stock Exchange on 10 March 2026.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"00570","symbol_name":"中國中藥","start_time":0,"source_url":"","article_id":"1176253694","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1176253694","pubTimestamp":1773132204,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"China Traditional Chinese Medicine Holdings Co. Limited (TRAD CHI MED, 00570) will convene a board meeting on 20 March 2026 to review and approve the consolidated financial results for the year ended...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"00570":"中国中药"},"translate_title":"TRAD CHI MED(00570)定于2026年3月20日召开董事会批准2025财年业绩并评估末期股息","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"00570":1},"content_text":"China Traditional Chinese Medicine Holdings Co. Limited (TRAD CHI MED, 00570) will convene a board meeting on 20 March 2026 to review and approve the consolidated financial results for the year ended 31 December 2025. The agenda also includes deliberation on the declaration of a potential final dividend.\nThe board currently comprises 12 directors: three executive directors (YANG Jun, LI Hongjian, PENG Li), five non-executive directors (LIU Haijian, LI Xiangrong, ZU Jing, XU Jinghui, HUANG Hao) and four independent non-executive directors (XIE Rong, YU Tze Shan Hailson, QIN Ling, LI Weidong).\nThe company disclosed the meeting schedule through an announcement filed with the Hong Kong Stock Exchange on 10 March 2026.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}